Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Diclofenac Sodium 1% Gel vs Voltaren Gel in Knee Osteoarthritis
NCT01456611Phase 3Completed
- Sponsor
- Anchen Pharmaceuticals, Inc.
- Start
- Sep 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in osteoarthritis (OA) (3 arms), sponsored by Anchen Pharmaceuticals, Inc. Primary endpoint: Mean Change from Baseline in WOMAC Pain Scale at 4 weeks. Started Sep 2011; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01456611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456611.